Intraocular Pressure Lowering, Change of Antiapoptotic Molecule Expression, and Neuroretinal Changes by Dorzolamide 2%/Timolol 0.5% Combination in a Chronic Ocular Hypertension Rat Model

The aim of this study was to examine intraocular pressure lowering, change of antiapoptotic molecules expression, and neuroretinal changes by a commercially available dorzolamide 2%/timolol 0.5% combination in a chronic ocular hypertension rat model. Chronic ocular hypertension was induced by three...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of ocular pharmacology and therapeutics 2008-12, Vol.24 (6), p.563-571
Hauptverfasser:	PARK, Hae Y, LEE, Na Y, KIM, Jie H, PARK, Chan K
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals bcl-X Protein - genetics Biological and medical sciences Cell Survival - drug effects Disease Models, Animal Drug Combinations Glaucoma and intraocular pressure Glial Fibrillary Acidic Protein - analysis Intraocular Pressure - drug effects Male Medical sciences Ocular Hypertension - drug therapy Ocular Hypertension - pathology Ocular Hypertension - physiopathology Ophthalmology Pharmacology. Drug treatments Proto-Oncogene Proteins c-bcl-2 - genetics Rats Rats, Sprague-Dawley Retinal Ganglion Cells - drug effects Retinal Ganglion Cells - pathology RNA, Messenger - analysis Sulfonamides - administration & dosage Thiophenes - administration & dosage Timolol - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!